Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma

Cancer

Volumn 83, Issue 7, 1998, Pages 1335-1343

  Koppán, Miklós ^a,b,c   Halmos, Gábor ^a,b   Arencibia, José M ^a,b   Lamharzi, Najib ^a,b   Schally, Andrew V ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Antagonists; Bombesin; Epidermal growth factor receptors; Gastrin releasing peptide; Small cell lung carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GASTRIN ANTAGONIST; GASTRIN RELEASING PEPTIDE; RC 3095; RC 3940 II; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CONTROLLED STUDY; LUNG SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; BLOTTING, SOUTHERN; BOMBESIN; CARCINOMA, SMALL CELL; GASTRIN-RELEASING PEPTIDE; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032189492     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981001)83:7<1335::AID-CNCR10>3.0.CO;2-5     Document Type: Article

References (60)

1. Ihde DC. Small cell lung cancer. Chest 1995;107:243-48.
2. Schally AV, Comaru-Schally AM. Hypothalamic and other peptide hormones. In: Holland JF, Frei E III, Bast RC Jr., Kufe DE, Morton DL, Weichselbaum RR, editors. Cancer medicine. 3rd edition. Baltimore: Williams and Wilkins, 1997: 1067-85.
3. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985;316:823-6.
4. Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL. Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer 1987;55:513-6.
5. Damstrup L, Rygaard K, Spang-Thomsen M, Poulson HS. Expression of the epidermal growth factor receptor in human small cell lung cancer cell lines. Cancer Res 1992;52: 3089-93.
6. Moody TW, Cuttitta F. Growth factor and peptide receptors in small cell lung cancer. Life Sci 1993;52:1161-73.
7. Moody TW, Carney DN, Cuttitta F, Quattrocchi K, Minna JD. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. Life Sci 1985;37:105-13.
8. Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K, et al. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice. Br J Cancer 1994;70:886-92.
9. Von Schrenck T, Heinz-Erian P, Moran T, Mantey SA, Gardner JD, Jenson RT. Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am J Physiol 1989;256:747-58.
10. Fathi Z, Corjay MH, Shapira J, Wada E, Benya R, Jensen R, et al. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J Biol Chem 1993;268:5979-84.
11. Spindel ER, Giladi E, Segerson TP, Nagalla S. Bombesin-like peptides: of ligands and receptors. Recent Prog Horm Res 1993;48:365-91.
12. Nagalla SR, Barry BJ, Creswick KC, Eden P, Taylor JT, Spindel ER. Cloning of a receptor for amphibian [Phe13]-bombesin distinct from the receptor for gastrin-releasing peptide: identification of a fourth bombesin receptor subtype (BB4). Proc Natl Acad Sci USA 1995;92:6205-9.
13. Gill GN, Bertics PJ, Santon JB. Epidermal growth factor and its receptor. Mol Cell Endocrinol 1987;51:169-86.
14. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-12.
15. Liebow C, Crean DH, Lee MT, Kamer AR, Mang TS, Schally AV. Synergistic effects of bombesin and epidermal growth factor on cancers. Proc Natl Acad Sci USA 1994;91:3804-8.
16. Liebow C, Lee MT, Krebs L, Schally AV. Bombesin may stimulate growth through up-regulation of EGF receptors [abstract]. Pancreas 1992;7:746.
17. Lee MT, Liebow C, Krebs LJ, Schally AV. Bombesin and gastrin releasing peptide (GRP) induce phosphorylation and up-regulation of epidermal growth factor receptor [abstract]. Proc Annu Meet Am Assoc Cancer Res 1993;34: 244.
18. Szepeshazi K, Schally AV, Cai RZ, Radulovic S, Milovanovic S, Szöke B. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters. Cancer Res 1991;51:5980-6.
19. Szepeshazi K, Schally AV, Halmos G, Groot K, Radulovic S. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095. J Natl Cancer Inst 1992;84:1915-22.
20. Szepeshazi K, Schally AV, Groot K, Halmos G. Effect of bombesin, gastrin-releasing peptide (GRP) (14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters. Int J Cancer 1993;54:282-9.
21. Yano T, Pinski J, Groot K, Schally AV. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines. Cancer Res 1992;52:4545-7.
22. Yano T, Pinski J, Szepeshazi K, Halmos G, Radulovic S, Groot K, et al. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice. Cancer 1994;73:1229-38.
23. Jungwirth A, Galvan G, Pinski J, Halmos G, Szepeshazi K, Cai RZ, et al. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate 1997;32:164-72.
24. Jungwirth A, Pinski J, Galvan G, Halmos G, Szepeshazi K, Cai RZ, et al. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinizing-hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II. Eur J Cancer 1997;33: 1141-8.
25. Radulovic S, Cai RZ, Serfözö P, Groot K, Redding TW, Pinski J, et al. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi. Int J Pept Protein Res 1991;38:593-600.
26. 2 or its derivatives. Proc Natl Acad Sci USA 1994;91:12664-8.
27. 2 show high binding affinity to BN/GRP receptors on CFPAC-1 human pancreatic cancer cells. Int J Oncol 1995; 6:1165-72.
28. 2. Int J Oncol 1995;7:749-54.
29. Halmos G, Pinski J, Szöke B, Schally AV. Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer. Cancer Lett 1994; 85:111-8.
30. Halmos G, Schally AV. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. Proc Natl Acad Sci USA 1997;94:956-60.
31. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980;107:220-39.
32. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd edition. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989.
33. Gordon AW, Joyce CP, Gibbes RJ, Bhanu K, Nelly A, Stromberg K. mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cells. Cancer Lett 1995;89:63-71.
34. Steel RGD, Torrie J. Principles and procedures of statistics. New York: McGraw-Hill, 1976.
35. 8]phyllolitorin promote fetal mouse lung branching morphogenesis via a receptor-mediated mechanism. Proc Natl Acad Sci USA 1995;92:4357-61.
36. Siegfried JM, Guentert PJ, Gaither AL. Effects of bombesin and gastrin-releasing peptide on human bronchial epithelial cells from a series of donors: individual variation and modulation by bombesin analogs. Anat Rec 1993;236:241-7.
37. Weber S, Zuckerman JE, Bostwick DG, Bensch KG, Sikic BI, Raffin TA. Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. J Clin Invest 1985;75: 306-9.
38. Layton JE, Scanlon DB, Soveny C, Morstyn G. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro. Cancer Res 1988;48:4783-9.
39. Rozengurt E. Bombesin stimulation of mitogenesis; specific receptors, signal transaction, and early events. Am Rev Respir Dis 1990;142:S11-5.
40. Mahmoud S, Staley J, Taylor J, Bogden A, Moreau JP, Coy D, et al. [Psi13,14]bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res 1991;51: 1798-802.
41. Cai RZ, Radulovic S, Pinski J, Nagy A, Redding T, Olsen D, et al. Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi. Peptides 1992;13:267-71.
42. Sethi T, Langdon S, Smyth J, Rozengurt E. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res 1992;52(9 Suppl):2737-42.
43. Langdon S, Sethi T, Ritchie A, Muir M, Smythe J, Rozengurt E. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo. Cancer Res 1992;52: 4554-7.
44. Pinski J, Halmos G, Schally AV. Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. Cancer Lett 1993;71:189-96.
45. Pinski J, Halmos G, Yano T, Szepeshazi K, Qin Y, Ertl T, et al. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160. Int J Cancer 1994;57:574-80.
46. Qin Y, Ertl T, Cai RZ, Halmos G, Schally AV. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res 1994;54:1035-41.
47. Qin Y, Halmos G, Cai RZ, Szöke B, Ertl T, Schally AV. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors. J Cancer Res Clin Oncol 1994;120:519-28.
48. Van Lint J, Agostinis P, Merlevede W, Vandenheede JR. Early responses in mitogenic signaling, bombesin induced protein phosphorylations in Swiss 3T3 cells. Adv Enzyme Regul 1993;33:143-55.
49. Palumbo A, Rossino P, Comoglio P. Bombesin stimulates c-fos gene expression in Swiss 3T3 cells. Exp Cell Res 1986; 167:276-80.
50. Rozengurt E, Sinnett-Smith J. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitotic response. J Cell Physiol 1987;131:218-25.
51. Rozengurt E, Sinnett-Smith J. Bombesin stimulation of fibroblast mitogenesis: specific receptors, signal transduction and early events. Phil Trans R Soc Lond B 1990;327:209-21.
52. Benya RV, Fathi Z, Kusui T, Pradhan T, Battey JF, Jensen RT. Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization, and growth: possible role for cyclic AMP. Mol Pharmacol 1994;46:235-45.
53. Draoui M, Chung P, Park M, Birrer M, Jakowlew S, Moody TW. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells. Peptides 1995;16:289-92.
54. Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem 1990;265:7709-12.
55. Boonstra J, De Laat SW, Ponec M. Epidermal growth factor receptor expression related to differentiation capacity in normal and transformed keratinocytes. Exp Cell Res 1985; 161:421-33.
56. Yonemura Y, Sugiyama K, Fujimura T, Kamata T, Fushida S, Yamaguchi A. Epidermal growth factor receptor status and S-phase fractions in gastric carcinoma. Oncology 1989;46: 158-61.
57. Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987;1:1398-402.
58. Nicholson S, Sainsbury JRC, Halcrow P, Chambers P, Farndon JR, Harris AL. Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet 1989;1:182-5.
59. Singletary SE, Baker FL, Spitzer G, Tucker SL, Tomasovic B, Brock WA, et al. Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res 1987; 47:403-6.
60. Haeder M, Rotsch M, Bepler G, Hennig C, Havemann K, Heimann B, et al. Epidermal growth factor receptor expression in human lung cancer cell lines. Cancer Res 1988;48: 1132-6.